Cargando…
IL-17A Increases Multiple Myeloma Cell Viability by Positively Regulating Syk Expression
PURPOSE: Elevated IL-17 produced by T(h)17 cells was reported to promote myeloma cell growth and inhibit immune function in multiple myeloma (MM). IL-17A was also reported to promote MM growth through IL-17 receptors and enhance adhesion to bone marrow stromal cells (BMSCs). Spleen tyrosine kinase (...
Autores principales: | Wang, Shunye, Ma, Yanan, Wang, Xudong, Jiang, Jie, Zhang, Chenglu, Wang, Xinfeng, Jiang, Yijing, Huang, Hongming, Hong, Liu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556560/ https://www.ncbi.nlm.nih.gov/pubmed/31174059 http://dx.doi.org/10.1016/j.tranon.2019.04.023 |
Ejemplares similares
-
Circ-SMARCA5 suppresses progression of multiple myeloma by targeting miR-767-5p
por: Liu, Haiyan, et al.
Publicado: (2019) -
The Prognostic Role of Cyclin D1
in Multiple Myeloma: A Systematic
Review and Meta-Analysis
por: Jiang, Yuwen, et al.
Publicado: (2022) -
Type 2 diabetes mellitus does not increase the risk of multiple myeloma: a systematic review and meta-analysis
por: Zhang, Chenlu, et al.
Publicado: (2020) -
Analysis of the anti-proliferative and the pro-apoptotic efficacy of Syk inhibition in multiple myeloma
por: Koerber, Ruth-Miriam, et al.
Publicado: (2015) -
Targeting IL-17A in Multiple Myeloma: A Potential Novel Therapeutic Approach in Myeloma
por: Prabhala, Rao H., et al.
Publicado: (2015)